Table of Contents
ISRN Pharmaceutics
Volume 2012, Article ID 251247, 8 pages
http://dx.doi.org/10.5402/2012/251247
Research Article

Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method

1Department of Chemistry, Sri Krishnadevaraya University, Anantapur 515003, Andhra Pradesh 515003, India
2Hetero Labs Ltd., Hetero House, Sanathnagar, 500078 Andhra Pradesh, Hyderabad, India
3InvaGen Pharmaceuticals Inc., Hauppauge 11749, NY, USA

Received 12 March 2012; Accepted 31 May 2012

Academic Editors: M. Nasr and C. J. Salomon

Copyright © 2012 Kondru Sudhakar Babu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Pitt, W. Remme, and F. Zannad, “Eplerenone post acute myocardial infarction heart failure efficacy and survival study investigators,” ACC Current Journal Review, vol. 12, no. 4, p. 57, 2003. View at Google Scholar
  2. E. Burgess, J. Niegowksa, K.-W. Tan, M. S. Kipnes, B. Roniker, and J. L. Patrick, “OR-51: antihypertensive effects of eplerenone and enalapril in patients with essential hypertension,” American Journal of Hypertension, vol. 15, no. 4, supplement 1, p. A23, 2002. View at Google Scholar
  3. M. A. Olayioye, I. Beuvink, K. Horsch, J. M. Daly, and N. E. Hynes, “ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinases,” The Journal of Biological Chemistry, vol. 274, no. 24, pp. 17209–17218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Steven Wiley and P. M. Burke, “Regulation of receptor tyrosine kinase signaling by endocytic trafficking,” Traffic, vol. 2, no. 1, pp. 12–18, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. B. A. Pearlman, A. G. Padilla, J. T. Hach, J. L. Havens, and M. D. Pillai, “A new approach to the furan degradation problem involving ozonolysis of the trans-enedione and its use in a cost-effective synthesis of eplerenone,” Organic Letters, vol. 8, no. 10, pp. 2111–2113, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Y. Zhang, D. M. Fast, and A. P. Breau, “Development and validation of a liquid chromatography-tandem mass spectrometric assay for Eplerenone and its hydrolyzed metabolite in human plasma,” Journal of Chromatography B, vol. 787, no. 2, pp. 333–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Rane, K. Patil, J. Sangshetti, R. Yeole, and D. Shinde, “Stability-indicating RP-HPLC method for analysis of eplerenone in the bulk drug and in a pharmaceutical dosage form,” Acta Chromatographica, vol. 21, no. 4, pp. 619–629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. International Conference on Harmonization, “Validation of analytical procedures: text and methodology Q2 (R1),” in International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2005.
  9. International Conference on Harmonization, “Stability testing of New Drug Substances and Products Q1 (R2),” in International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2000.
  10. International Conference on Harmonization, “Photo stability testing of new drug substances and products Q1B,” in International Conference on Harmonization, IFPMA, Geneva, Switzerland, 1996.
  11. S. Singh and M. Bakshi, “Guidance on Conduct of Stress tests to determine inherent stability of drugs,” Pharmaceutical Technology Online, pp. 1–24, 2000. View at Google Scholar
  12. International Conference on Harmonization, “Guidelines on validation of analytical Procedures definitions and terminology Q2A,” in International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2005.
  13. J. T. Carstensen and C. T. Rhodes, Drug Stability: Principles and Practices, Informa Healthcare, 3rd edition, 2000.
  14. M. Bakshi and S. Singh, “Development of validated stability-indicating assay methods—critical review,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 6, pp. 1011–1040, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. The United States Pharmacopeia.Validation of Compendial Methods, 32nd edition, 2008.
  16. International Conference on Harmonization, “Stability testing of new drug substances and products Q1 A (R2),” in International Conference on Harmonization, IFPMA, Geneva, Switzerland, 2003.